Sponsor hub
Memorial Sloan Kettering Cancer Center clinical trial failures
Review 60 stopped clinical trials from Memorial Sloan Kettering Cancer Center, including disease areas, phases, and classified stop reasons.
This page groups real ClinicalTrials.gov-derived stopped trial records. The strongest added signal is the stop-reason classification: 3 of these records are likely biological failure signals, while the rest may reflect operational, strategic, regulatory, funding, enrollment, or unclear stop reasons.
Dominant stop reasons
- OPERATIONAL
- 41
- OTHER/UNKNOWN
- 16
- SAFETY
- 2
- EFFICACY/FUTILITY
- 1
Notable sponsors
- Memorial Sloan Kettering Cancer Center
- 60
Related phases
- Phase II
- 34
- Phase I
- 16
- Unknown
- 6
- Early Phase I
- 2
- Phase III
- 2
Crawlable stopped-trial records
Open ExploreShowing up to 60 representative records from this slice. Each link opens the trial detail page with source attribution and stop-reason context.
Phase II Sarcoma trial by Memorial Sloan Kettering Cancer Center. Stop reason: OTHER/UNKNOWN.
Vendor decided study to be closed early
Phase II Lymphoma trial by Memorial Sloan Kettering Cancer Center. Stop reason: OPERATIONAL.
Lack of accrual
Phase I Pancreatic Cancer trial by Memorial Sloan Kettering Cancer Center. Stop reason: OTHER/UNKNOWN.
Study tracer is currently unavailable
Phase II Solid Tumor trial by Memorial Sloan Kettering Cancer Center. Stop reason: OPERATIONAL.
Lack of accrual
Phase II COVID-19 trial by Memorial Sloan Kettering Cancer Center. Stop reason: EFFICACY/FUTILITY.
Based on two large, multicenter, randomized trials showed no benefit to tocilizumab in this setting and study has been closed.
Phase II Mantle Cell Lymphoma trial by Memorial Sloan Kettering Cancer Center. Stop reason: OPERATIONAL.
Slow accrual rate
Early Phase I Breast Cancer trial by Memorial Sloan Kettering Cancer Center. Stop reason: OPERATIONAL.
No accruals
Phase II Breast Cancer trial by Memorial Sloan Kettering Cancer Center. Stop reason: OPERATIONAL.
PI left MSKCC
Phase II COVID-19 trial by Memorial Sloan Kettering Cancer Center. Stop reason: OTHER/UNKNOWN.
Emerging evidence does not support the use of HCQ for treatment or prevention of SARS -CoV2 infection. No pts have been enrolled.
Phase II Colorectal Cancer trial by Memorial Sloan Kettering Cancer Center. Stop reason: OPERATIONAL.
No accrual
Early Phase I Follicular Lymphoma trial by Memorial Sloan Kettering Cancer Center. Stop reason: OPERATIONAL.
Lack of accrual
Phase I Leukemia trial by Memorial Sloan Kettering Cancer Center. Stop reason: OPERATIONAL.
No patients were enrolled to this study since being open to enrollment. Due to changes in available therapies, there aren't enough people who will be eligible for the study. Therefore, the study was closed.
Phase II Acute Lymphoid Leukemia (ALL) trial by Memorial Sloan Kettering Cancer Center. Stop reason: OPERATIONAL.
Low accrual
Phase I Prostate Cancer trial by Memorial Sloan Kettering Cancer Center. Stop reason: OTHER/UNKNOWN.
Study drug not available per sponsor
Phase I Small Cell Lung Cancer trial by Memorial Sloan Kettering Cancer Center. Stop reason: SAFETY.
Due to DLTs
Phase II Breast Cancer trial by Memorial Sloan Kettering Cancer Center. Stop reason: OTHER/UNKNOWN.
Limited amount of eligible participants
Phase III Prostate Cancer trial by Memorial Sloan Kettering Cancer Center. Stop reason: OPERATIONAL.
Due to low accrual
Phase I Mesothelioma trial by Memorial Sloan Kettering Cancer Center. Stop reason: OTHER/UNKNOWN.
Sponsor terminated study agreement
Phase II Prostate Cancer trial by Memorial Sloan Kettering Cancer Center. Stop reason: OPERATIONAL.
Due to low accrual
Phase I Lymphoma trial by Memorial Sloan Kettering Cancer Center. Stop reason: OPERATIONAL.
Lack of accrual
Phase I Metastatic Breast Cancer trial by Memorial Sloan Kettering Cancer Center. Stop reason: OTHER/UNKNOWN.
The sponsor closed the study due to discontinuing their onapristone program
Phase I Relapsed/Refractory Multiple Myeloma trial by Memorial Sloan Kettering Cancer Center. Stop reason: OPERATIONAL.
Lack of accrual
Phase I Thyroid Cancer trial by Memorial Sloan Kettering Cancer Center. Stop reason: OPERATIONAL.
Lack of accrual
Phase II Esophagogastric Tumors trial by Memorial Sloan Kettering Cancer Center. Stop reason: OPERATIONAL.
Lack of accrual
Phase II Multiple Myeloma trial by Memorial Sloan Kettering Cancer Center. Stop reason: OPERATIONAL.
PI left institution and study is being transferred.
Phase II Fanconi Anemia trial by Memorial Sloan Kettering Cancer Center. Stop reason: OPERATIONAL.
Accrual has been slow
Unknown Penile Cancer trial by Memorial Sloan Kettering Cancer Center. Stop reason: OPERATIONAL.
The study was interrupted because of failure to recruit the target study population in a reasonable timeframe.
Phase II COVID-19 trial by Memorial Sloan Kettering Cancer Center. Stop reason: OTHER/UNKNOWN.
The study was terminated based results of other studies and use of the new vaccine.
Phase II Non-Malignant Hematologic Disorders trial by Memorial Sloan Kettering Cancer Center. Stop reason: OPERATIONAL.
Participant accrual low and the study was closed
Phase II Lymphoma trial by Memorial Sloan Kettering Cancer Center. Stop reason: OPERATIONAL.
Low accrual and lack of funding.
Phase II Thrombocytopenia trial by Memorial Sloan Kettering Cancer Center. Stop reason: OPERATIONAL.
Lack of accrual
Phase II EBV Lymphomas trial by Memorial Sloan Kettering Cancer Center. Stop reason: OPERATIONAL.
Lack of accrual
Phase II Gastric Cancer trial by Memorial Sloan Kettering Cancer Center. Stop reason: OPERATIONAL.
Low accrual rate
Phase II Hodgkin Lymphoma trial by Memorial Sloan Kettering Cancer Center. Stop reason: OPERATIONAL.
Lack of accrual
Phase II Neuroblastoma trial by Memorial Sloan Kettering Cancer Center. Stop reason: OPERATIONAL.
Low participant accrual
Unknown Leukemia trial by Memorial Sloan Kettering Cancer Center. Stop reason: OPERATIONAL.
Lack of accrual
Phase II Colorectal Adenocarcinoma Metastatic to the Liver trial by Memorial Sloan Kettering Cancer Center. Stop reason: OPERATIONAL.
Lack of accrual
Phase I Acute Myeloid Leukemia (AML) trial by Memorial Sloan Kettering Cancer Center. Stop reason: OTHER/UNKNOWN.
Study sponsor discontinued support
Unknown Acute Leukemia trial by Memorial Sloan Kettering Cancer Center. Stop reason: OPERATIONAL.
Closed due to poor accrual
Phase I Solitary Bone Plasmacytoma trial by Memorial Sloan Kettering Cancer Center. Stop reason: OTHER/UNKNOWN.
FDA recommendation
Unknown Acute Myeloid Leukemia (AML) trial by Memorial Sloan Kettering Cancer Center. Stop reason: OPERATIONAL.
Lack of accrual
Phase I Sarcoma trial by Memorial Sloan Kettering Cancer Center. Stop reason: OPERATIONAL.
Lack of accrual
Phase II Bladder Cancer trial by Memorial Sloan Kettering Cancer Center. Stop reason: SAFETY.
Safety reasons
Phase I Acute Lymphoblastic Leukemia (ALL) trial by Memorial Sloan Kettering Cancer Center. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Unknown CNS Cancer trial by Memorial Sloan Kettering Cancer Center. Stop reason: OPERATIONAL.
Lack of accrual
Phase I Malignant Pleural Mesothelioma trial by Memorial Sloan Kettering Cancer Center. Stop reason: OPERATIONAL.
Lack of accrual
Phase II Myeloproliferative Neoplasms trial by Memorial Sloan Kettering Cancer Center. Stop reason: OTHER/UNKNOWN.
patient safety
Phase II Fallopian Tube Cancer trial by Memorial Sloan Kettering Cancer Center. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase I Renal Cancer trial by Memorial Sloan Kettering Cancer Center. Stop reason: OTHER/UNKNOWN.
Given the number of toxicities seen and the difficulty with patient retention in the dose escalation portion, the sponsor decided to close the trial.
Phase II Bladder Cancer trial by Memorial Sloan Kettering Cancer Center. Stop reason: OPERATIONAL.
Lack of accrual
Phase II Leukemia trial by Memorial Sloan Kettering Cancer Center. Stop reason: OPERATIONAL.
Lack of accrual
Phase II Multiple Myeloma and Plasma Cell Neoplasm trial by Memorial Sloan Kettering Cancer Center. Stop reason: OPERATIONAL.
Lack of Accrual
Phase II Lung Cancer trial by Memorial Sloan Kettering Cancer Center. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase III Bladder Cancer trial by Memorial Sloan Kettering Cancer Center. Stop reason: OPERATIONAL.
Lack of accrual
Phase II Colon Cancer trial by Memorial Sloan Kettering Cancer Center. Stop reason: OPERATIONAL.
Lack of accrual
Phase II Melanoma trial by Memorial Sloan Kettering Cancer Center. Stop reason: OPERATIONAL.
Lack of accrual
Phase II Lung Cancer trial by Memorial Sloan Kettering Cancer Center. Stop reason: OPERATIONAL.
Lack of accrual
Phase II Bladder Cancer trial by Memorial Sloan Kettering Cancer Center. Stop reason: OPERATIONAL.
Lack of accrual
Phase I Lymphoma trial by Memorial Sloan Kettering Cancer Center. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Unknown Colon Cancer trial by Memorial Sloan Kettering Cancer Center. Stop reason: OPERATIONAL.
Lack of accrual